Paper Details

  1. Home
  2. Paper Details

Intralesional Measles, Mumps, and Rubella Vaccine Versus Intralesional <i>Candida</i> Antigen in the Treatment of Common and Plantar Warts.

Author: AlakadRania, El-ArabReda Ezz, NasrMohamed, NofalAhmad

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study evaluated the efficacy and safety of intralesional measles, mumps, and rubella (MMR) vaccine compared with intralesional Candida antigen in 68 patients with multiple common and plantar warts. The study found that intralesional MMR vaccine resulted in a higher therapeutic response rate and lower recurrence rate compared to intralesional Candida antigen.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Intralesional immunotherapy has been effectively used in the treatment of warts; however, comparative studies between different antigens are limited. OBJECTIVE: To evaluate the efficacy and safety of intralesional measles, mumps, and rubella (MMR) vaccine compared with intralesional M...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1177/1203475421991130

データ提供：米国国立医学図書館（NLM）

Treating Warts with Immunotherapy: MMR Vaccine vs. Candida Antigen

This study compares the effectiveness of intralesional immunotherapy using MMR vaccine and Candida antigen in treating common and plantar warts. It's like discovering two different approaches to clearing a stubborn patch of desert vegetation! The study found that both methods were effective, but MMR vaccine showed greater promise.

The War on Warts: A Battle of Immune Systems

This study explores the use of immunotherapy in treating warts, a common skin condition. The researchers compared the efficacy of MMR vaccine and Candida antigen in stimulating the immune system to fight off these pesky invaders, revealing a promising new approach to treating these persistent skin lesions.

A New Weapon Against Warts: MMR Vaccine

This study suggests that MMR vaccine may be a more effective treatment for warts than Candida antigen. It's like finding a more potent weapon in the desert arsenal against these troublesome skin growths. The study's findings provide valuable insights into the potential of MMR vaccine as a promising therapy for warts.

Dr. Camel's Conclusion

This research highlights the potential of immunotherapy in treating warts, a common skin condition. It's like finding a new oasis where the immune system can be revitalized to fight off these persistent invaders. This study offers a promising avenue for developing more effective and targeted therapies for warts.
Date :
  1. Date Completed 2021-12-13
  2. Date Revised 2021-12-14
Further Info :

Pubmed ID

33533654

DOI: Digital Object Identifier

10.1177/1203475421991130

Related Literature

Article Analysis
・Effective treatment of rubella
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.